undamentalytics Newsletter
Sign in

Petco Health & Wellness Company, Inc. (WOOF) stock

Add to watchlist

Add holding +

NASDAQ: WOOF Nasdaq Other Specialty Retail Next results ~November 24, 2026

C+ Fundamentals grade

Petco Health & Wellness Company, Inc. is a US-listed company in the other specialty retail industry. Its financial year ends in January.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: after-tax interest is 214% of the cash flow left for shareholders; our flat discount rate doesn't yet reflect debt this heavy.

Price vs value

Under review: after-tax interest is 214% of the cash flow left for shareholders; our flat discount rate doesn't yet reflect debt this heavy. We'll show the comparison once resolved.

Petco Health & Wellness Company, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 2 selling0 purchases and 5 sales by directors and officers, last 12 monthsInsider trades
  • Funds80 adding, 102 cuttingOf 36 active managers that changed their stake, 14 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Petco Health & Wellness files

Where Petco Health & Wellness stands after its latest 10-Q

Revenue for the twelve months to August 2026 was $5.97bn, down 1.3% on a year earlier, a smaller fall than the 1.9% decline a quarter earlier. That puts it 14 of 17 for growth among the other specialty retail companies we cover. Free-cash-flow margin rose to 4.0% from 1.0% a year earlier. The diluted share count is up 3.7% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades C. It passes 2 of our 7 financial-health checks.

Our model value for Petco Health & Wellness is under review, so past values are not shown until it is resolved.

Source: 10-Q filed September 4, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 24, 2026 (estimated)

Petco Health & Wellness Company, Inc.'s trailing-twelve-month revenue fell 1.3% year on year, with a free-cash-flow margin of 4.0%.

Our discounted-cash-flow model values the business at ~$6.5 per share in the base case (~$4.3–$9.3 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Results well ahead of expectations: Reported earnings per share beat the analysts' consensus estimate by 112% in the quarter to 2026-07-31, the 3rd beat in the last four quarters.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

Nothing in Petco Health & Wellness Company, Inc.'s latest figures clears our strength thresholds.

Things to watch

  • Revenue shrinking. Revenue fell 1.3% over the last 12 months.
  • Share dilution. Diluted shares rose 3.7% in a year.
  • Volatile shares. Over the past year the shares showed annualised volatility of 60% and a beta of 0.6 against the S&P 500.
  • Heavily shorted. 20.1% of the shares available to trade are sold short (6.5 days of average volume to cover).

Latest results: FY2027 Q2

Filed September 4, 2026
Earnings per share
$0.15 against an average estimate of $0.07: beat by 111.7%
Revenue
$1.49bn, up 0.0% on a year earlier
Share reaction
-2.3% in the first session after the results on September 2, 2026, against +1.5% for the S&P 500
Next report
September 2, 2026; average EPS estimate $0.04

Petco Health & Wellness' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-1.8%
  • 1 week+8.5%
  • 1 month+22.8%
  • This year-2.5%
  • 1 year-15.4%
  • 5 years-89.5%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$6B
Operating margin
2.2%
Net margin
0.5%
EPS (TTM, diluted)
$0.10

Growth

Revenue growth
−1.3%
Change in growth rate
+0.6 pts
Share count change
+3.7%

Cash

Free cash flow (TTM)
$238M
FCF margin
4.0%
Stock pay % of revenue
0.5%

Earnings

Last results
September 2, 2026
Next results (est.)
November 24, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Leadership
  3. Leadership

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Petco Health & Wellness Company, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: held for review: after-tax interest is 214% of the cash flow left for shareholders; our flat discount rate doesn't yet reflect debt this heavy.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value Petco Health & Wellness Company, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 10.3%: the 10-year Treasury yield (4.9%) plus a beta of 1.19 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. — Does not apply: This model is withheld pending its input or assumption review.
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$3.5 ~$2.4–$5.4 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: This model is withheld pending its input or assumption review.
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: This model is withheld pending its input or assumption review.
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Petco Health & Wellness Company, Inc. with Other Specialty Retail in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 202120222023202420252026Now
Share price$26.03$18.30$11.74$2.48$3.42$2.69$2.74
Market value$5m$5m$3.1bn$664m$935m$770m$792m
+ Net debt (− = net cash)−$111m−$212m−$202m−$125m−$166m−$257m$591m
Enterprise value−$106m−$207m$2.9bn$538m$769m$513m$1.4bn
Multiples
Price / sales 0.0x0.0x0.5x0.1x0.2x0.1x0.1x
Price / earnings —0.0x34.4x——84.9x26.1x
Price / free cash flow 0.1x0.0x45.9x—18.8x4.1x3.3x
EV / EBITDA n/mn/m7.0x—3.6x1.6x4.2x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

22 /100

Weak moat

How hard Petco Health & Wellness's competitive advantage looks for rivals to wear away, judged from 6 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 1 / 20

    Cash operating profit has been a median 2.3% of total assets over 5 years.

  • Pricing power 14 / 20

    Gross margin has been a median 39.1%, moving by 1.7 percentage points (standard deviation) across 6 years.

  • Durability 0 / 20

    Operating margin has been a median 2.6%; its worst year was -20.0%.

  • Cash conversion 7 / 20

    Free cash flow was positive in 4 of 6 years, at a median 1.5% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (27 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $0.26 +36% $6.0bn +1%
Next $0.27 +4% $6.1bn +1%

Next year's EPS estimate has moved −3.7% in 90 days, across 8 analysts.

Earnings against estimates

Quarter toEstimateActualSurprise
Jul 2026 $0.07 $0.15 +111.7%
Apr 2026 $0.03 $0.03 −12.7%
Jan 2026 $0.04 $0.04 +8.7%
Oct 2025 $0.02 $0.04 +73.9%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

12 analysts, Oct 2026
Buy217%
Hold867%
Sell217%

Monthly trend

  1. Oct 2026118212
  2. Sep 2026118212
  3. Aug 2026118212

Counts of recommendations published by analysts covering Petco Health & Wellness Company, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
20.1%
of tradable shares
Days to cover
6.48
at average volume
Short interest, 1 month
−2%
to September 30, 2026
Held by institutions
—
of shares
Held by insiders
3.3%
of shares
Employees
29,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Recent prices are available. Older price history and the statistics that need it are being loaded in the background.

What moved the share price

Last 12 months −13.8%

$3.18 on October 31, 2025 to $2.74

ThenNowEffect
Revenue (last 12 months) $6.0bn $6.0bn −1.3%
P/S multiple 0.1x 0.1x −9.4%
Share count 279m 289m −3.6%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 20222023202420252026 to date
Return
WOOF−52%−67%+21%−26%−3%
Industry peers (median)−27%+3%−23%−10%−21%
S&P 500−18%+26%+25%+18%+11%
Months that ended higher
WOOF25%33%25%42%55%
S&P 50042%67%75%75%46%
Largest fall from a high during the year
WOOF−60%−78%−53%−43%−40%
S&P 500−25%−10%−8%−19%−9%

Worst fall since January 14, 2021: 95% from January 14, 2021 to April 30, 2024. Getting back needed a 1860% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$2.18 – $3.62
From 52-week high
−24.3%
vs 50-day average
+12.4%
vs 200-day average
+2.7%
Volatility (1 year)
60%
Beta vs S&P 500
0.60

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
7 up, 5 down
typical move ±21.8%
After a week
6 up, 6 down
typical move ±26.0%
After a month
6 up, 6 down
typical move ±26.2%
Results releasedNext dayS&P 500 next day5 days21 days
September 2, 2026 −2.3% +1.5% −5.8% −15.1%
June 3, 2026 −3.2% −0.3% −4.4% −12.8%
March 11, 2026 +38.6% −1.6% +38.6% +19.7%
November 25, 2025 +21.9% +1.6% +12.2% +5.0%
August 28, 2025 +24.7% −0.2% +14.7% +13.4%
June 5, 2025 −22.1% +0.5% −27.0% −13.8%
March 26, 2025 +30.0% −1.5% +35.2% +25.1%
December 5, 2024 +4.8% 0.0% −9.5% −17.6%
September 10, 2024 +43.2% +1.5% +72.6% +88.4%
May 22, 2024 +29.4% −1.0% +60.4% +53.5%
March 13, 2024 −19.5% −0.4% −22.7% −32.8%
November 29, 2023 −21.4% +0.3% −9.4% −17.7%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Petco Health & Wellness Company, Inc. in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Petco Health & Wellness Company, Inc.
$5.9B $6B $6.1B $6.2B $6.3B FY24 Q3 FY25 Q2 FY26 Q1 FY27 Q2 Revenue (TTM), FY24 Q3: $6.2B Revenue (TTM), FY24 Q4: $6.3B Revenue (TTM), FY25 Q1: $6.2B Revenue (TTM), FY25 Q2: $6.2B Revenue (TTM), FY25 Q3: $6.2B Revenue (TTM), FY25 Q4: $6.1B Revenue (TTM), FY26 Q1: $6.1B Revenue (TTM), FY26 Q2: $6B Revenue (TTM), FY26 Q3: $6B Revenue (TTM), FY26 Q4: $6B Revenue (TTM), FY27 Q1: $6B Revenue (TTM), FY27 Q2: $6B $6B

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue (TTM)
FY24 Q3 $6.2B
FY24 Q4 $6.3B
FY25 Q1 $6.2B
FY25 Q2 $6.2B
FY25 Q3 $6.2B
FY25 Q4 $6.1B
FY26 Q1 $6.1B
FY26 Q2 $6B
FY26 Q3 $6B
FY26 Q4 $6B
FY27 Q1 $6B
FY27 Q2 $6B
Revenue growth, TTM YoY Petco Health & Wellness Company, Inc.
-4% -2% 0% 2% 4% FY24 Q3 FY25 Q2 FY26 Q1 FY27 Q2 Revenue growth, TTM YoY, FY24 Q3: 3.1% Revenue growth, TTM YoY, FY24 Q4: 3.6% Revenue growth, TTM YoY, FY25 Q1: 1.8% Revenue growth, TTM YoY, FY25 Q2: 0.9% Revenue growth, TTM YoY, FY25 Q3: 1.3% Revenue growth, TTM YoY, FY25 Q4: -2.2% Revenue growth, TTM YoY, FY26 Q1: -2.4% Revenue growth, TTM YoY, FY26 Q2: -2.8% Revenue growth, TTM YoY, FY26 Q3: -3.9% Revenue growth, TTM YoY, FY26 Q4: -2.5% Revenue growth, TTM YoY, FY27 Q1: -1.9% Revenue growth, TTM YoY, FY27 Q2: -1.3% -1.3%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue growth, TTM YoY
FY24 Q3 3.1%
FY24 Q4 3.6%
FY25 Q1 1.8%
FY25 Q2 0.9%
FY25 Q3 1.3%
FY25 Q4 -2.2%
FY26 Q1 -2.4%
FY26 Q2 -2.8%
FY26 Q3 -3.9%
FY26 Q4 -2.5%
FY27 Q1 -1.9%
FY27 Q2 -1.3%
Operating margin (TTM) Petco Health & Wellness Company, Inc.
-30% -20% -10% 0% 10% FY24 Q3 FY25 Q2 FY26 Q1 FY27 Q2 Operating margin (TTM), FY24 Q3: -17.9% Operating margin (TTM), FY24 Q4: -18.9% Operating margin (TTM), FY25 Q1: -19.7% Operating margin (TTM), FY25 Q2: -20.0% Operating margin (TTM), FY25 Q3: -0.2% Operating margin (TTM), FY25 Q4: 0.1% Operating margin (TTM), FY26 Q1: 0.7% Operating margin (TTM), FY26 Q2: 1.3% Operating margin (TTM), FY26 Q3: 1.8% Operating margin (TTM), FY26 Q4: 2.0% Operating margin (TTM), FY27 Q1: 2.2% Operating margin (TTM), FY27 Q2: 2.2% 2.2%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Operating margin (TTM)
FY24 Q3 -17.9%
FY24 Q4 -18.9%
FY25 Q1 -19.7%
FY25 Q2 -20.0%
FY25 Q3 -0.2%
FY25 Q4 0.1%
FY26 Q1 0.7%
FY26 Q2 1.3%
FY26 Q3 1.8%
FY26 Q4 2.0%
FY27 Q1 2.2%
FY27 Q2 2.2%
FCF margin (TTM) Petco Health & Wellness Company, Inc.
-2% 0% 2% 4% FY24 Q3 FY25 Q2 FY26 Q1 FY27 Q2 FCF margin (TTM), FY24 Q3: 1.0% FCF margin (TTM), FY24 Q4: -0.2% FCF margin (TTM), FY25 Q1: -0.4% FCF margin (TTM), FY25 Q2: -0.5% FCF margin (TTM), FY25 Q3: -0.2% FCF margin (TTM), FY25 Q4: 0.8% FCF margin (TTM), FY26 Q1: 0.8% FCF margin (TTM), FY26 Q2: 1.0% FCF margin (TTM), FY26 Q3: 2.2% FCF margin (TTM), FY26 Q4: 3.1% FCF margin (TTM), FY27 Q1: 2.7% FCF margin (TTM), FY27 Q2: 4.0% 4.0%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period FCF margin (TTM)
FY24 Q3 1.0%
FY24 Q4 -0.2%
FY25 Q1 -0.4%
FY25 Q2 -0.5%
FY25 Q3 -0.2%
FY25 Q4 0.8%
FY26 Q1 0.8%
FY26 Q2 1.0%
FY26 Q3 2.2%
FY26 Q4 3.1%
FY27 Q1 2.7%
FY27 Q2 4.0%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2020 Feb 2020 2021 Jan 2021 2022 Jan 2022 2023 Jan 2023 2024 Feb 2024 2025 Feb 2025 2026 Jan 2026 LTM Aug 2026
Income
Revenue 4,435 4,920 5,807 6,036 6,255 6,116 5,961 5,965
Gross profit 1,907 2,107 2,427 2,427 2,354 2,324 2,305 2,315
EBITDA 284 369 439 419 −977 216 317 330
Operating income 111 194 266 226 −1,180 7 120 133
Net income −96 −26 164 91 −1,280 −102 9 30
Diluted EPS −$0.46 −$0.13 $0.62 $0.34 −$4.78 −$0.37 $0.03 $0.10
Growth (year on year)
Revenue — +11.0% +18.0% +3.9% +3.6% −2.2% −2.5% −1.3%
EBITDA — +30.0% +18.8% −4.4% −332.9% — +47.1% +14.3%
Operating income — +75.8% +36.9% −15.2% −623.3% — — —
Net income — — — −44.8% — — — —
Diluted EPS — — — −45.2% — — — —
Margins
Gross margin 43.0% 42.8% 41.8% 40.2% 37.6% 38.0% 38.7% 38.8%
EBITDA margin 6.4% 7.5% 7.6% 6.9% −15.6% 3.5% 5.3% 5.5%
Operating margin 2.5% 4.0% 4.6% 3.7% −18.9% 0.1% 2.0% 2.2%
Net margin −2.2% −0.5% 2.8% 1.5% −20.5% −1.7% 0.2% 0.5%
Free-cash-flow margin −1.1% 2.2% 2.1% 1.1% −0.2% 0.8% 3.1% 4.0%
Cash flow
Cash from operations 110 269 358 346 216 178 314 374
Capital spending 157 160 239 278 226 128 127 136
Free cash flow −47 109 119 68 −10 50 187 238
Stock-based pay 9 13 49 61 82 50 33 32
Free cash flow after stock pay −56 96 70 7 −92 −1 154 205
Balance sheet
Cash 155 111 212 202 125 166 257 293
Total debt — — — — — — — 885
Net debt (negative = net cash) −155 −111 −212 −202 −125 −166 −257 591
Diluted shares — — — 266m 268m 273m 286m 289m
Returned to shareholders
Buybacks — 0 — — — — — —
Total returned — 0 — — — — — —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 7 checks passed · August 1, 2026
What it owns · $5.2bn
Short-term assets $1.1bnLonger-term assets $4.1bn
What it owes, and who funded it · $5.2bn
Short-term liabilities $1.2bnLonger-term liabilities $2.8bnShareholders' equity $1.2bn
  • Short-term assets cover short-term liabilities $1.1bn of assets due within a year against $1.2bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities $1.1bn short-term assets against $2.8bn of longer-dated liabilities.
  • More cash than debt $293m of cash against $591m of debt.
  • Debt below 40% of shareholders' equity Debt is 49% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 72% to 49% over five years.
  • A year's operating cash flow covers at least 20% of debt $374m of operating cash flow against $591m of debt.
  • Operating profit covers interest at least five times over Operating income of $133m against $130m of interest.

From Petco Health & Wellness Company, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Diluted share count
+3.7%
year over year
Sales & admin spending
36.6%
of revenue

Competitors: side by side with peers

Closest by revenue in other specialty retail
Last 12 months unless stated WOOF ASO FIVE BBWI SBH MNSO Median
Revenue, last 12 months $6.0bn $6.2bn $5.3bn $7.2bn $3.7bn $3.0bn $1.2bn
Revenue growth, last 12 months −1.3% 3.7% 25.6% −2.2% 1.1% 26.3% 4.0%
Revenue growth, 3-year average −1.1% −0.1% 17.8% −1.1% −0.4% — 2.6%
Revenue growth, latest quarter 0.0% 3.0% 22.9% −2.3% 0.2% — 2.3%
Gross margin 38.8% 35.8% 40.3% 44.1% 52.1% 45.0% 36.5%
Operating margin 2.2% 9.6% 14.7% 16.7% 8.4% 15.4% 2.2%
Operating margin, 3-year average −5.5% 9.4% 10.9% 17.1% 8.3% — 1.5%
Net margin 0.5% 6.4% 11.7% 10.8% 5.2% 5.6% 0.8%
Cash from operations / revenue 6.3% 8.8% 15.1% 17.7% 9.9% 12.0% 5.5%
Free-cash-flow margin 4.0% 5.3% 11.3% 14.3% 6.5% 6.4% 3.0%
Free-cash-flow margin, 3-year average 1.5% 5.4% 6.6% 11.4% 5.1% — 2.7%
Stock pay / revenue 0.5% 0.4% 0.6% 0.3% 0.6% 1.7% 0.6%
Change in share count 3.7% −4.5% 0.6% −5.5% −4.2% −1.1% 0.7%

Median of all 35 companies we cover in other specialty retail. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

35 other specialty retail companies
Measure Company Peer median Rank
Revenue growth Growth -1.3% 4.0% 26 of 35
Change in growth rate Growth +0.6pp -0.2pp 12 of 35
Gross margin Profitability 38.8% 36.5% 14 of 31
Operating margin Profitability 2.2% 2.2% 17 of 33
Net margin Profitability 0.5% 0.8% 20 of 35
Free-cash-flow margin Cash generation 4.0% 3.1% 14 of 34
Stock pay as % of revenue Cash generation 0.5% 0.7% 11 of 30
Long-term debt as % of assets Balance sheet 11.4% 14.2% 13 of 26
Change in share count Balance sheet 3.7% 0.6% 25 of 33

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to January 31, 2026
Products and services
Line of business Revenue Share YoY
Products $4.9B 82.8% ▼ 3.5%
Consumables $3B 60.1% ▼ 2.5%
Supplies and Companion Animals $2B 39.9% ▼ 5.1%
Services and Other $1B 17.2% ▲ 2.6%

From Petco Health & Wellness Company, Inc.'s 10-K filed March 13, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$818M
Institutions reporting
193
Shares held vs prior quarter
▲ 1.0%
Positions opened / closed
22 / 31

Top buyers and sellers, Q2 2026: 80 institutions bought and 102 sold ; the biggest buyer was Royce & Associates LP (+2.6M shares) and the biggest seller Jane Street Group, LLC (−879K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Cvc Management Holdings Ii Ltd. $397M 145.9M 48.5% 0.0%
Canada Pension Plan Investment Board $163M 59.8M 19.9% 0.0%
Dimensional Fund Advisors LP $30.1M 11.1M 3.7% ▲ 9.5%
Long Focus Capital Management, LLC $22.8M 8.4M 2.8% ▲ 4.5%
Blackrock, Inc. $22M 8.1M 2.7% ▼ 1.6%
Two Sigma Investments, LP $15.2M 5.6M 1.9% ▼ 6.6%
Holocene Advisors, LP $13.3M 4.9M 1.6% ▼ 14.9%
Cresset Asset Management, LLC $10.5M 3.9M 1.3% 0.0%
Vanguard Capital Management LLC $10.5M 3.8M 1.3% ▲ 10.3%
FMR LLC $10.4M 3.8M 1.3% ▼ 7.6%
Nuveen, LLC $9.9M 3.6M 1.2% ▼ 10.2%
Jpmorgan Chase & Co $7.7M 2.8M 0.9% ▲ 65.7%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Petco Health & Wellness Company, Inc.'s complete shareholder register. Values are as reported by the filers ; 2 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $1.7M 5 trades by 2 insiders · 0% under pre-set plans
Net ▼ $1.7M net selling
Insider Date Trade Shares Price Value
May Holly Chief Human Resources Officer July 9, 2026 Sell 200,000 $2.54 $508,000
May Holly Chief Human Resources Officer July 8, 2026 Sell 150,000 $2.55 $382,500
May Holly Chief Human Resources Officer July 7, 2026 Sell 100,000 $2.55 $255,000
Venezia Patrick J Chief Revenue Officer March 13, 2026 Sell 102,029 $3.42 $348,939
Venezia Patrick J Chief Revenue Officer December 1, 2025 Sell 74,192 $3.08 $228,511

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around November 24, 2026 estimated from the company's past filing pattern, not announced

  • September 2, 2026
  • June 3, 2026
  • March 11, 2026
  • November 25, 2025
  • August 28, 2025
  • June 5, 2025

Recent SEC filings

Data status

When each part of this page on Petco Health & Wellness Company, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Petco Health & Wellness Company, Inc. in brief

What does Petco Health & Wellness Company, Inc. do?
Petco Health & Wellness Company, Inc. is a US-listed company in the other specialty retail industry. Its financial year ends in January.
What is Petco Health & Wellness Company, Inc.'s stock ticker?
Petco Health & Wellness Company, Inc. trades under the ticker WOOF on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Petco Health & Wellness Company, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Petco Health & Wellness Company, Inc. reported revenue of $6B, 1.3% lower than a year earlier, according to its SEC filings.
What is Petco Health & Wellness Company, Inc.'s free cash flow?
Petco Health & Wellness Company, Inc.'s free-cash-flow margin is 4.0% of revenue over the trailing twelve months, ranking 14 of the 34 other specialty retail companies we cover.
Who are Petco Health & Wellness Company, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Cvc Management Holdings Ii Ltd., Canada Pension Plan Investment Board and Dimensional Fund Advisors LP. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Petco Health & Wellness Company, Inc.'s market cap?
On November 2, 2026, Petco Health & Wellness Company, Inc.'s market capitalisation was about $792M, with a price-to-earnings ratio of 26.1 and net debt of $591M. Market figures come from third-party market data and may be delayed.
How much debt does Petco Health & Wellness Company, Inc. have?
Petco Health & Wellness Company, Inc.'s debt-to-equity ratio is 48.9%, from its latest balance sheet (72.1% five years earlier). The financial health section below sets out its other solvency checks.
Who are Petco Health & Wellness Company, Inc.'s competitors?
In our Other Specialty Retail peer group, the companies closest to Petco Health & Wellness Company, Inc. are Academy Sports & Outdoors, Inc., Five Below, Inc, Bath & Body Works, Inc., Sally Beauty Holdings, Inc. and Miniso Group Holding Ltd. The side-by-side comparison below sets their revenue, margins and growth against Petco Health & Wellness Company, Inc.'s.
Are insiders buying or selling Petco Health & Wellness Company, Inc. stock?
Over the last 12 months, Petco Health & Wellness Company, Inc.'s directors and officers reported 0 open-market purchases and 5 sales on Form 4. The insider trading page charts every trade.
When is Petco Health & Wellness Company, Inc.'s next earnings date?
Around November 24, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Petco Health & Wellness Company, Inc. announces its own schedule.